Cancer gene therapy

被引:14
作者
Douglas, JT
机构
[1] Univ Alabama Birmingham, Div Human Gene Therapy, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Surg, Gene Therapy Ctr, Birmingham, AL 35294 USA
关键词
cancer; gene therapy; vector; ENZYME PRODRUG THERAPY; INHIBITS TUMOR-GROWTH; DOMINANT-NEGATIVE MUTANTS; CYTOSINE DEAMINASE GENE; THYMIDINE KINASE GENE; DOUBLE SUICIDE GENE; HUMAN BREAST-CANCER; WILD-TYPE P53; IN-VIVO; OVARIAN-CANCER;
D O I
10.1177/153303460300200107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer gene therapy is the transfer of genetic material to the cells of an individual with the goal of eradicating cancer cells, both in the primary tumor and metastases. Cancer gene therapy strategies exploit our expanding knowledge of the genetic basis of cancer, thereby allowing rationally targeted interventions at the molecular level. The successful implementation of cancer gene therapy in the clinic awaits the development of vectors capable of specific and efficient gene delivery to cancer cells. The first clinical applications of cancer gene therapy are likely to be in combination with conventional therapies, such as radiotherapy and immunotherapy.
引用
收藏
页码:51 / 63
页数:13
相关论文
共 118 条
[1]  
Adachi Y, 2001, CANCER RES, V61, P7882
[2]  
Adachi Y, 2000, CANCER RES, V60, P4305
[3]  
Aghi M, 1999, CANCER RES, V59, P3861
[4]   Synergistic anticancer effects of ganciclovir/thymidine kinase and 5-fluorocytosine/cytosine deaminase gene therapies [J].
Aghi, M ;
Kramm, CM ;
Chou, TC ;
Breakefield, XO ;
Chiocca, EA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (05) :370-380
[5]   Reovirus therapy of lymphoid malignancies [J].
Alain, T ;
Hirasawa, K ;
Pon, KJ ;
Nishikawa, SG ;
Urbanski, SJ ;
Auer, Y ;
Luider, J ;
Martin, A ;
Johnston, RN ;
Janowska-Wieczorek, A ;
Lee, PWK ;
Kossakowska, AE .
BLOOD, 2002, 100 (12) :4146-4153
[6]   Replicative adenoviruses for cancer therapy [J].
Alemany, R ;
Balagué, C ;
Curiel, DT .
NATURE BIOTECHNOLOGY, 2000, 18 (07) :723-727
[7]   Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv [J].
Arafat, WO ;
Gómez-Navarro, J ;
Buchsbaum, DJ ;
Xiang, J ;
Wang, M ;
Casado, E ;
Barker, SD ;
Mahasreshti, PJ ;
Haisma, HJ ;
Barnes, MN ;
Siegal, GP ;
Alvarez, RD ;
Hemminki, A ;
Nettelbeck, DM ;
Curiel, DT .
GENE THERAPY, 2002, 9 (04) :256-262
[8]   Targeted adenoviral vectors [J].
Barnett, BG ;
Crews, CJ ;
Douglas, JT .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1575 (1-3) :1-14
[9]   Dual targeting of adenoviral vectors at the levels of transduction and transcription enhances the specificity of gene expression in cancer cells [J].
Barnett, BG ;
Tillman, BW ;
Curiel, DT ;
Douglas, JT .
MOLECULAR THERAPY, 2002, 6 (03) :377-385
[10]  
Bauerschmitz GJ, 2002, CANCER RES, V62, P1266